Pharmacokinetics of liposomal amphotericin B in pleural fluid

Antimicrob Agents Chemother. 2010 Apr;54(4):1633-5. doi: 10.1128/AAC.01438-09. Epub 2010 Jan 19.

Abstract

We report the penetration of liposomal amphotericin B into the pleural fluid of a patient with pulmonary zygomycosis and empyema. The ratio of area under the concentration-versus-time curve in pleural fluid (AUC(pleural fluid)) to that in serum (AUC(serum)) for liposomal amphotericin B over 24 h was 9.4%, with pleural fluid concentrations of 2.12 to 4.91 microg/ml. Given the relatively low level of intrapleural penetration of liposomal amphotericin B, chest tube drainage may be warranted for successful treatment of zygomycotic empyema.

Publication types

  • Case Reports
  • Research Support, N.I.H., Intramural

MeSH terms

  • Amphotericin B / administration & dosage
  • Amphotericin B / blood
  • Amphotericin B / pharmacokinetics*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / blood
  • Antifungal Agents / pharmacokinetics*
  • Empyema, Pleural / drug therapy
  • Empyema, Pleural / metabolism
  • Female
  • Humans
  • Liposomes
  • Lung Diseases, Fungal / blood
  • Lung Diseases, Fungal / drug therapy*
  • Lung Diseases, Fungal / metabolism*
  • Middle Aged
  • Mucormycosis / blood
  • Mucormycosis / drug therapy*
  • Mucormycosis / metabolism*
  • Pleural Effusion / drug therapy
  • Pleural Effusion / metabolism*

Substances

  • Antifungal Agents
  • Liposomes
  • liposomal amphotericin B
  • Amphotericin B